Dr. Geoffrey Guy, chairman and founder of cannabinoid medicine pioneer, GW Pharma, outlines the potential benefits that Brexit could bring to the…

Canada's medical cannabis market is valued as a USD 1.3 billion market opportunity, with the recreational market potential worth over USD eight…

The global regulatory landscape for medical cannabis, showing the countries in which medical cannabis and cannabinoid treatments are legal /…

While many Canadian medical cannabis outfits cover the entire value chain, from research and development through to manufacturing and distribution,…

“If you are trying to be everything to everybody, you end up being nothing to no one”—Michael Gorenstein, CEO of The Cronos Group talks to…

Prof. Claude A. Farrugia of the Malta Chamber of Commerce, Enterprise and Industry documents the main trends in the manufacturing industry of Malta…

With already 20 percent of market share in the medical cannabis sector in Canada, MedReleaf is getting ready for the upcoming legalization of cannabis…

Despite its relative youth, Canada’s medical cannabis industry is already presenting some of the characteristics of the much more mature…

Having just announced the first collaboration between a medical cannabis company and a major pharmaceutical player, Tilray expects to launch its first…

After 35 years in the pharmaceutical industry, Barry Fishman shares his excitement about heading one of Canada’s leading licensed cannabis…

With a diverse pipeline to back up its projects, Tetra Bio-Pharma wants to be the first Canadian pharmaceutical company to launch a cannabis-based…

Heading Canada’s largest cannabis Business to Business Retailer, John Fowler, CEO of The Supreme Cannabis Company, offers a novel approach looking…